PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

DeFronzo RA et al. - Saxagliptin once daily added to metformin therapy was generally well tolerated and led to statistically significant improvements in glycemic indices vs. placebo added to metformin in patients with type 2 diabetes inadequately controlled on metformin alone.

Related Articles

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 84%

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09    Relevance Score: 83%

Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09    Relevance Score: 83%

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09    Relevance Score: 83%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09    Relevance Score: 83%

Today in Endocrinology...keeping you current

The Obesity Paradox in the Elderly: Potential Mechanisms and Clinical Implications
Clinics in Geriatric Medicine, 12/01/09

Diabetes and Cardiovascular Disease Prevention in Older Adults
Clinics in Geriatric Medicine, 12/01/09

Identification of persons with dysglycemia: Terminology and practical significance
Primary Care Diabetes, 12/01/09